{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000340.3:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T variant"
        },
        {
          "HGVS": "NM_000340.3:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K variant"
        },
        {
          "HGVS": "NM_000340.3:c.626G>A",
          "cDNA Change": {
            "transcript": "NM_000340.3",
            "ref": "G",
            "alt": "A",
            "position": "626"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "209"
          },
          "Description in input context": "G209A variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005032"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro aggregation assays and cell culture experiments",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y or HEK293",
        "Description": "Experiments were conducted using SH-SY5Y or HEK293 cell lines to study alpha-synuclein aggregation and toxicity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000340.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased aggregation and toxicity",
          "Result Description": "The A53T variant significantly enhanced alpha-synuclein aggregation and neuronal toxicity."
        },
        {
          "Variant": "NM_000340.3:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased aggregation and toxicity",
          "Result Description": "The E46K variant promoted alpha-synuclein aggregation and induced neurodegeneration in cell models."
        },
        {
          "Variant": "NM_000340.3:c.626G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased aggregation and toxicity",
          "Result Description": "The G209A variant led to higher alpha-synuclein oligomerization and cytotoxicity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal aggregation levels (e.g., <20% insoluble protein) and low toxicity.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Abnormal aggregation levels (e.g., >50% insoluble protein) and high toxicity.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}